Back to homepage
Skip navigation
Home
News
Breast cancer information
Multimedia product overview
Clinical trials
Key publications
Slide library
Patient information
Prescribing information
Congress Calendar
Congress Reports
Links
Contact us
Home
Welcome to Zoladex.net
, an international educational resource for healthcare professionals with an interest in breast cancer treatment, provided by AstraZeneca. This site is not intended for the following audiences who should use the links below:
US Citizens
should visit
BreastCancerProfessional.com
UK Patients
should visit
AstraZeneca.co.uk
UK Physicians
should visit
CancerLineUK.net
Journalists
should visit
AstraZenecaPressOffice.com
Patients and carers (non US and non UK)
should visit
PatientHealthInternational.com.
ZOLADEX is also used for the treatment of prostate cancer, please visit
ZOLADEX in prostate cancer.
Latest news
Features
9 May 2008
:
Lipophilic stains alter biology of emergent breast cancer
8 May 2008
:
Inherited germline mutations influence breast cancer survival
8 May 2008
:
THC inhibits breast cancer cell proliferation through JunD
7 May 2008
:
Ionizing radiation induces oncogene amplification, breast cancer
Treating with 'Zoladex'
: a section intended for healthcare providers including nurses and featuring the Zoladex SafeSystem
Multimedia Product Overview
: explaining efficacy, tolerability, dosage and much more using diagrams and voice
Living with 'Zoladex'
: a section intended for healthcare providers including nurses, providing information for sharing with your patients
AstraZeneca websites
Search
Advanced Search
Site map
Information for
This is an AstraZeneca International website for healthcare professionals. The site is not intended for the following audiences who should use the links below:
US Citizens
UK Patients
UK Physicians
Journalists
Site services
Printer friendly
Terms of use
Privacy policy
© All rights reserved